Concepedia

Martin Gutierrez

MG

23

Publications

5.2K

Citations

17

H-Index

2007

Active since

Affiliations

Hackensack University Medical Center(Current)

Bristol-Myers Squibb (United States)

Memorial Sloan Kettering Cancer Center

Johns Hopkins University

Dana-Farber Cancer Institute

Martin Gutierrez is an author at Hackensack University Medical Center specializing in medicine, cancer therapeutics, and radiation oncology.

ORCID

Top concepts

Publications per year

2007–2023

23

Publications

23

PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma

Stephen M. Ansell, Alexander M. Lesokhin, Ivan Borrello et al. · New England Journal of Medicine · 2014 · 3.5K citations · Full text

Phase 0 Clinical Trial of the Poly (ADP-Ribose) Polymerase Inhibitor ABT-888 in Patients With Advanced Malignancies

Shivaani Kummar, Robert J. Kinders, Martin Gutierrez et al. · Journal of Clinical Oncology · 2009 · 324 citations · Full text

Phase II Study of Dose-Adjusted EPOCH and Rituximab in Untreated Diffuse Large B-Cell Lymphoma With Analysis of Germinal Center and Post-Germinal Center Biomarkers

Wyndham H. Wilson, Kieron Dunleavy, Stefania Pittaluga et al. · Journal of Clinical Oncology · 2008 · 303 citations · Full text

Hand-Foot Skin Reaction Increases with Cumulative Sorafenib Dose and with Combination Anti-Vascular Endothelial Growth Factor Therapy

Nilofer S. Azad, Jeanny B. Aragon‐Ching, William L. Dahut et al. · Clinical Cancer Research · 2009 · 140 citations · Full text

A Phase 1 Study of Nivolumab in Combination with Ipilimumab for Relapsed or Refractory Hematologic Malignancies (CheckMate 039)

Stephen M. Ansell, Martin Gutierrez, Margaret A. Shipp et al. · Blood · 2016 · 134 citations

Rows per page

1–5 of 23